Provectus Biopharmaceuticals, Inc. Share Price
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0690 USD | -0.87% |
|
+3.60% | +23.43% |
| 25/06 | Provectus Biopharmaceuticals, Inc. Launches Veripure Open Science Program For Medical Research Access To PV-10 | CI |
| 19/06 | Provectus Biopharmaceuticals, Inc. - Shareholder/Analyst Call |
| Market Cap | 2.9Cr 2.54Cr 2.33Cr 2.17Cr 4.12Cr 276.11Cr 4.18Cr 28Cr 11Cr 135.72Cr 11Cr 11Cr 467.7Cr | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 3.17Cr 2.77Cr 2.55Cr 2.38Cr 4.51Cr 302.08Cr 4.57Cr 31Cr 12Cr 148.49Cr 12Cr 12Cr 511.69Cr | EV / Sales 2024 |
8,64,51,912x | EV / Sales 2025 | 7,80,13,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Provectus Biopharmaceuticals, Inc.
| 1 day | -0.87% | ||
| 1 week | +3.60% | ||
| Current month | -0.58% | ||
| 1 month | +13.67% | ||
| 3 months | +44.35% | ||
| 6 months | +8.15% | ||
| Current year | +23.43% |
| 1 week | 0.06 |  | 0.07 |
| 1 month | 0.06 | | 0.07 |
| Current year | 0.04 | | 0.07 |
| 1 year | 0.04 | | 0.1 |
| 3 years | 0.04 | | 0.22 |
| 5 years | 0.03 | | 0.22 |
| 10 years | 0.01 | | 0.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 16/04/2024 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/05/2012 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 25/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 03/04/2017 | |
John Lacey
BRD | Director/Board Member | 78 | 27/04/2018 |
Edward Pershing
CHM | Chairman | 73 | 27/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/06 | Free | Director | 48,917 | 0.5182% | ||
| 30/06 | Free | Chief Executive Officer | 45,860 | 0.4858% | ||
| 30/06 | Free | Chairperson | 45,860 | 0.4858% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.87% | +3.60% | -11.42% | -43.16% | 2.9Cr | |
| +0.68% | +5.92% | +77.86% | +139.22% | 5.91TCr | |
| +2.32% | +5.03% | +75.26% | +91.40% | 5.52TCr | |
| +3.86% | +6.93% | -11.32% | -9.53% | 2.47TCr | |
| +4.30% | +7.95% | +14.11% | +437.83% | 2.42TCr | |
| +4.74% | +13.68% | +43.36% | -4.67% | 1.97TCr | |
| -0.29% | +9.78% | +43.90% | -28.41% | 1.76TCr | |
| 0.00% | +20.78% | +186.15% | +361.42% | 1.62TCr | |
| +6.72% | +19.38% | +37.85% | - | 1.48TCr | |
| +3.50% | +1.97% | +21.02% | +191.95% | 1.4TCr | |
| Average | +2.50% | +7.65% | +47.68% | +126.23% | 2.46TCr | |
| Weighted average by Cap. | +2.46% | +6.47% | +58.32% | +136.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.54 0.5 0.46 0.88 58.76 0.89 5.95 2.31 28.88 2.32 2.27 99.53 | 0.34 0.29 0.27 0.25 0.48 32 0.48 3.24 1.26 15.73 1.26 1.23 54.21 |
| Net income | -47.62L -41.63L -38.26L -35.66L -67.64L -45Cr -68.67L -4.59Cr -1.79Cr -22Cr -1.79Cr -1.75Cr -77Cr | -54.31L -47.48L -43.63L -40.67L -77.14L -52Cr -78.31L -5.24Cr -2.04Cr -25Cr -2.04Cr -1.99Cr -88Cr |
| Net Debt | 28.77L 25.15L 23.12L 21.55L 40.87L 27Cr 41.49L 2.78Cr 1.08Cr 13Cr 1.08Cr 1.06Cr 46Cr | 27.27L 23.84L 21.91L 20.42L 38.74L 26Cr 39.33L 2.63Cr 1.02Cr 13Cr 1.02Cr 1Cr 44Cr |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $0.0690 | -0.87% | 66,450 |
| 01/26/01 | $0.0696 | +0.29% | 1,38,519 |
| 30/26/30 | $0.0694 | +3.58% | 2,90,653 |
| 29/26/29 | $0.0670 | +0.60% | 1,27,532 |
| 26/26/26 | $0.0666 | -4.04% | 1,14,224 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
